The new “COVID-19” section is now available from the Certest website, with useful information about the virus, development of the pandemic and the products for diagnostic Certest Biotec is developing to collaborate in the global response to this serious disease.

Through simple navigation, users have quick access to all available diagnostic kits, both PCR and Rapid Test, as well as the Certest bioSCIENCE family. bioSCIENCE develops monoclonal antibodies and recombinant proteins which are the basis for the development of Lateral Flow, CLIA and ELISA diagnostic assays.

The new section is now available online: